ELDN Presents BESTOW Results
Eledon presents long-term extension phase 2 BESTOW results showing sustained higher kidney function and improved patient-reported outcomes with Tegoprubart compared with Tacrolimus
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.